Department of Pathology and Clinical Laboratories, National Cancer Centre Hospital, Tokyo, Japan; Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan; Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.
Clinical Laboratory Division, Kansai Medical University Hirakata Hospital, Osaka, Japan.
J Thorac Oncol. 2016 Dec;11(12):2141-2149. doi: 10.1016/j.jtho.2016.07.034. Epub 2016 Aug 27.
An association between usual interstitial pneumonia (UIP) and carcinogenesis has been well established. However, few detailed analyses have investigated the clinicopathological, immunohistochemical, and genetic features of patients with primary lung adenocarcinoma (ADC) with UIP (UIP-ADC).
We identified 44 patients with ADC in the setting of UIP (the UIP-ADC group) (1.9%) from 2309 patients with primary ADC and compared clinicopathological, immunohistochemical, and genetic features between the UIP-ADC group and patients with ADC without UIP (the non-UIP-ADC group).
Clinicopathological features of UIP-ADC included an older age at occurrence; male predominance; smoking history; predilection for the lower lobe; large tumor size; high incidence of lymph vessel invasion, pleural invasion, and lymph node metastasis; and poor survival rate. However, the cause of death of patients with UIP-ADC was largely influenced by respiratory complications. Histologically, patients in the UIP-ADC group could be stratified according to invasive mucinous-predominant subtype. Genetically, patients in the UIP-ADC group had lower EGFR and higher KRAS mutation rates compared with patients in the non-UIP-ADC group.
UIP-ADC was associated with a poor prognosis owing to the high frequency of perioperative complications rather than the malignancy of the tumor itself. There was a high prevalence of the invasive mucinous-predominant subtype in cases of UIP-ADC. UIP-ADC also had a low prevalence of EGFR mutations and a high prevalence of KRAS mutations. These findings suggest that UIP-ADC should be distinct from non-UIP-ADC.
特发性间质性肺炎(UIP)与癌变之间存在关联已得到充分证实。然而,很少有详细分析研究过具有 UIP 的原发性肺腺癌(ADC)患者的临床病理、免疫组织化学和遗传特征。
我们从 2309 例原发性 ADC 患者中确定了 44 例 UIP 下的 ADC(UIP-ADC 组)(1.9%),并比较了 UIP-ADC 组与无 UIP 的 ADC 患者(非-UIP-ADC 组)的临床病理、免疫组织化学和遗传特征。
UIP-ADC 的临床病理特征包括发病年龄较大;男性为主;吸烟史;下叶偏好;肿瘤较大;淋巴管浸润、胸膜侵犯和淋巴结转移发生率高;生存率低。然而,UIP-ADC 患者的死亡原因主要受呼吸并发症影响。组织学上,UIP-ADC 组可根据侵袭性黏液型为主的亚型进行分层。从遗传学角度来看,UIP-ADC 组患者的 EGFR 突变率较低,KRAS 突变率较高,而非-UIP-ADC 组患者。
UIP-ADC 预后不良,这是由于围手术期并发症的高频率,而不是肿瘤本身的恶性程度。UIP-ADC 中侵袭性黏液型为主的亚型患病率较高。UIP-ADC 中 EGFR 突变的发生率较低,KRAS 突变的发生率较高。这些发现表明 UIP-ADC 应与非-UIP-ADC 区分开来。